• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床试验中的期中分析:经典方法与贝叶斯方法

Interim analyses in clinical trials: classical vs. Bayesian approaches.

作者信息

Berry D A

出版信息

Stat Med. 1985 Oct-Dec;4(4):521-6. doi: 10.1002/sim.4780040412.

DOI:10.1002/sim.4780040412
PMID:4089353
Abstract

This paper concerns interim analysis in clinical trials involving two treatments from the points of view of both classical and Bayesian inference. I criticize classical hypothesis testing in this setting and describe and recommend a Bayesian approach in which sampling stops when the probability that one treatment is the better exceeds a specified value. I consider application to normal sampling analysed in stages and evaluate the gain in average sample number as a function of the number of interim analyses.

摘要

本文从经典推断和贝叶斯推断的角度探讨了涉及两种治疗方法的临床试验中的期中分析。我批评了这种情况下的经典假设检验,并描述和推荐了一种贝叶斯方法,即在一种治疗方法更好的概率超过指定值时停止抽样。我考虑了在分阶段分析的正态抽样中的应用,并评估了作为期中分析次数函数的平均样本数的增益。

相似文献

1
Interim analyses in clinical trials: classical vs. Bayesian approaches.临床试验中的期中分析:经典方法与贝叶斯方法
Stat Med. 1985 Oct-Dec;4(4):521-6. doi: 10.1002/sim.4780040412.
2
Predictive checking for Bayesian interim analyses in clinical trials.临床试验中贝叶斯期中分析的预测性检验
Contemp Clin Trials. 2008 Sep;29(5):740-50. doi: 10.1016/j.cct.2008.05.005. Epub 2008 May 20.
3
An introduction to the Bayesian analysis of clinical trials.临床试验的贝叶斯分析介绍。
Ann Emerg Med. 1993 Aug;22(8):1328-36. doi: 10.1016/s0196-0644(05)80119-2.
4
[Comparison of Bayesian interim analysis and classical interim analysis in group sequential design].[成组序贯设计中贝叶斯期中分析与经典期中分析的比较]
Nan Fang Yi Ke Da Xue Xue Bao. 2015 Nov;35(11):1638-42.
5
Bayesian interim analysis in clinical trials.临床试验中的贝叶斯期中分析。
Contemp Clin Trials. 2008 Sep;29(5):751-5. doi: 10.1016/j.cct.2008.05.007. Epub 2008 Jun 4.
6
Sample size reestimation by Bayesian prediction.基于贝叶斯预测的样本量重新估计
Biom J. 2007 Jun;49(3):365-77. doi: 10.1002/bimj.200310273.
7
Bayesian predictive approach for inference about proportions.用于比例推断的贝叶斯预测方法。
Stat Med. 1995;14(9-10):1057-63; discussion 1064. doi: 10.1002/sim.4780140924.
8
Bayesian inference under cluster sampling with probability proportional to size.基于大小与概率成比例的聚类抽样的贝叶斯推断。
Stat Med. 2018 Nov 20;37(26):3849-3868. doi: 10.1002/sim.7892. Epub 2018 Jul 4.
9
Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials.用于临床试验中两个比例非劣效性检验的贝叶斯样本量计算
Contemp Clin Trials. 2008 Jul;29(4):507-16. doi: 10.1016/j.cct.2007.12.001. Epub 2007 Dec 23.
10
Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.基于二次损失函数的贝叶斯决策理论组序贯临床试验设计:频率学派评估
Clin Trials. 2007;4(1):5-14. doi: 10.1177/1740774506075764.

引用本文的文献

1
Bayesian interim analysis and efficiency of phase III randomized trials.贝叶斯期中分析与III期随机试验的效率
Br J Cancer. 2025 Aug 11. doi: 10.1038/s41416-025-03156-5.
2
CONSORT 2025 explanation and elaboration: updated guideline for reporting randomised trials.CONSORT 2025解释与阐述:随机对照试验报告的更新指南
BMJ. 2025 Apr 14;389:e081124. doi: 10.1136/bmj-2024-081124.
3
Improving the Effectiveness of Sample Size Re-Estimation: An Operating Characteristic Focused, Hybrid Frequentist-Bayesian Approach.提高样本量重新估计的有效性:一种以操作特征为重点的混合频率主义-贝叶斯方法。
Stat Med. 2025 Feb 10;44(3-4):e10310. doi: 10.1002/sim.10310.
4
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.治疗诱导的衰老有助于阿贝西利在去分化脂肪肉瘤患者中的疗效。
Clin Cancer Res. 2024 Feb 16;30(4):703-718. doi: 10.1158/1078-0432.CCR-23-2378.
5
Bayesian estimation of the binomial parameter in sequential experiments.序贯试验中二项分布参数的贝叶斯估计
Stat Methods Med Res. 2023 Nov;32(11):2158-2171. doi: 10.1177/09622802231199160. Epub 2023 Sep 7.
6
Informed Bayesian survival analysis.知情贝叶斯生存分析。
BMC Med Res Methodol. 2022 Sep 10;22(1):238. doi: 10.1186/s12874-022-01676-9.
7
Adaptive treatment allocation and selection in multi-arm clinical trials: a Bayesian perspective.多臂临床试验中的适应性治疗分配和选择:贝叶斯视角。
BMC Med Res Methodol. 2022 Feb 20;22(1):50. doi: 10.1186/s12874-022-01526-8.
8
Effectiveness of an Annular Closure Device to Prevent Recurrent Lumbar Disc Herniation: A Secondary Analysis With 5 Years of Follow-up.环形闭合装置预防复发性腰椎间盘突出症的有效性:5 年随访的二次分析。
JAMA Netw Open. 2021 Dec 1;4(12):e2136809. doi: 10.1001/jamanetworkopen.2021.36809.
9
The Bayesian Design of Adaptive Clinical Trials.自适应临床试验的贝叶斯设计。
Int J Environ Res Public Health. 2021 Jan 10;18(2):530. doi: 10.3390/ijerph18020530.
10
Bayesian design for two-arm randomized Phase II clinical trials with endpoints from the exponential family using multiple constraints.基于多重约束的双臂随机II期临床试验的贝叶斯设计,其终点来自指数族分布。
J Biopharm Stat. 2018;28(5):824-839. doi: 10.1080/10543406.2017.1402779. Epub 2017 Nov 27.